Atara Biotherapeutics

Pierre Fabre

Pharma

Pierre Fabre commits up to $640M in T-cell deal with Atara

In its attempt to win approval in the U.S. for Ebvallo, Atara is turning to the same partner it used to gain a green light in Europe—Pierre Fabre.

Kevin Dunleavy Nov 3, 2023 11:04am

immune diseases

Off-the-shelf T-cell therapy wins world-first approval

Dec 19, 2022 3:22pm

Podcast

Vaccine business

'The Top Line': Pfizer's kickback lawsuit, top vaccine companies

Oct 21, 2022 6:00am

European Medicines Agency

Atara's first-in-class allogeneic T-cell therapy nears EU nod

Oct 14, 2022 11:18am